The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Chindex International Inc. (NasdaqGS:CHDX) (“Chindex”) in connection with the sale of the Company to a consortium led by an affiliate of TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Robert Lipson, the CEO of Chindex.

Click here to learn about the case: There is no cost or obligation to you.

Under the terms of the transaction, Chindex shareholders will receive $19.50 for each share of Chindex stock they own. The investigation concerns whether the Chindex Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company to obtain the best possible value for Chindex shareholders, and whether Lipson is taking advantage of her position to purchase the Company at an unfair price.

If you own common stock in Chindex and wish to obtain additional information, please contact Vincent Wong, Esq. either via email, by telephone at 212.425.1140, or visit

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

Copyright Business Wire 2010